| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BBRC.2013.11.057 |
| P698 | PubMed publication ID | 24269813 |
| P50 | author | Weibin Wu | Q59688834 |
| P2093 | author name string | Jianxin Gu | |
| Bo Zhu | |||
| Xiaomin Peng | |||
| Dongwei Jia | |||
| Meiling Zhou | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | alcoholic liver disease | Q558404 |
| murine model | Q122890741 | ||
| P304 | page(s) | 68-73 | |
| P577 | publication date | 2013-11-20 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease | |
| P478 | volume | 443 |
| Q57111615 | Cholestasis-induced bile acid elevates estrogen level via farnesoid X receptor-mediated suppression of the estrogen sulfotransferase SULT1E1 |
| Q41791565 | Constitutive androstane receptor activation promotes bilirubin clearance in a murine model of alcoholic liver disease |
| Q38840947 | Curcumin attenuates ethanol-induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytes |
| Q55080645 | Deficiency of cholesterol 7α-hydroxylase in bile acid synthesis exacerbates alcohol-induced liver injury in mice. |
| Q50985405 | Effect of iron on cholesterol 7α-hydroxylase expression in alcohol-induced hepatic steatosis in mice. |
| Q30234425 | Emerging concepts in alcoholic hepatitis |
| Q94671522 | Enhanced alcoholic liver disease in mice with intestine-specific farnesoid X receptor deficiency |
| Q38979273 | FXR Agonists: From Bench to Bedside, a Guide for Clinicians |
| Q38359118 | FXR agonists as therapeutic agents for non-alcoholic fatty liver disease |
| Q91901530 | FXR deficiency alters bile acid pool composition and exacerbates chronic alcohol induced liver injury |
| Q57106885 | FXR deletion in hepatocytes does not affect the severity of alcoholic liver disease in mice |
| Q90127318 | Farnesoid X receptor (FXR) activation induces the antioxidant protein metallothionein 1 expression in mouse liver |
| Q34432554 | Farnesoid X receptor regulates forkhead Box O3a activation in ethanol-induced autophagy and hepatotoxicity |
| Q28253815 | Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis |
| Q26865988 | Insulin resistance in clinical and experimental alcoholic liver disease |
| Q38770951 | Mechanistic insight into nuclear receptor-mediated regulation of bile acid metabolism and lipid homeostasis by grape seed procyanidin extract (GSPE). |
| Q42380618 | MitoNEET Deficiency Alleviates Experimental Alcoholic Steatohepatitis in Mice by Stimulating Endocrine Adiponectin-Fgf15 Axis |
| Q45955303 | Modulation of the intestinal bile acid-FXR-FGF15 axis improves alcoholic liver disease in mice. |
| Q38261577 | New therapies for primary biliary cirrhosis |
| Q47419101 | Pregnane X receptor promotes ethanol-induced hepatosteatosis in mice |
| Q34464043 | Recent advances in the development of farnesoid X receptor agonists |
| Q34303001 | Recent insights into farnesoid X receptor in non-alcoholic fatty liver disease |
| Q28086898 | Role of farnesoid X receptor and bile acids in alcoholic liver disease |
| Q38887864 | Role of farnesoid X receptor in cholestasis |
| Q57114776 | Update on FXR Biology: Promising Therapeutic Target? |
Search more.